Soligenix Establishes At-The-Market Equity Offering Program

Soligenix ( (SNGX) ) just unveiled an update.

On January 23, 2026, Soligenix, Inc. entered into an at-the-market issuance sales agreement with Rodman & Renshaw, LLC, allowing the company, at its discretion, to sell up to $3.45 million of its common stock through Rodman as sales agent under an existing shelf registration. The agreement, which runs until the earlier of December 15, 2026, completion of the offering, termination by either party, or mutual agreement, gives Soligenix full control over sale parameters and imposes no obligation to issue shares, while Rodman earns up to a 3.0% commission on gross proceeds, highlighting a flexible capital-raising mechanism that can be activated or suspended depending on market conditions and the company’s financing needs.

The most recent analyst rating on (SNGX) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Soligenix stock, see the SNGX Stock Forecast page.

Spark’s Take on SNGX Stock

According to Spark, TipRanks’ AI Analyst, SNGX is a Neutral.

The score is primarily held down by weak financial performance (zero revenue, persistent losses, and continued cash burn), partially offset by balance-sheet improvement from deleveraging and positive equity. Technicals also weigh on the score due to a broadly weak trend, while valuation provides limited support given the negative P/E and lack of dividend data.

To see Spark’s full report on SNGX stock, click here.

More about Soligenix

Soligenix, Inc. is a publicly traded company listed on The Nasdaq Capital Market, issuing common stock with a par value of $0.001 per share and utilizing shelf registration statements to access U.S. capital markets as needed.

Average Trading Volume: 315,123

Technical Sentiment Signal: Sell

Current Market Cap: $13.92M

Learn more about SNGX stock on TipRanks’ Stock Analysis page.